Clinical trial
A Multi-center Prospective Study to Analyze Cancer-derived Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
NCT02771769 is registered in ClinicalTrials.gov with Chronix Biomedical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center Prospective Study to Analyze Cancer-derived Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
- Lead sponsor
- Chronix Biomedical Corporation
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2016
- Completion date
- January 1, 2020
- Enrollment
- 500 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.